The regulation of chondrocyte function by proinflammatory mediators -: Prostaglandins and nitric oxide

被引:179
作者
Goldring, MB
Berenbaum, F
机构
[1] Harvard Univ, Inst Med, Div Rheumatol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Inst Med, New England Baptist Bone & Joint Inst, Boston, MA 02115 USA
[3] CNRS, UMR 7079, Paris, France
[4] UFR St Antoine, Paris, France
关键词
D O I
10.1097/01.blo.0000144484.69656.e4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Within the mature articular cartilage matrix, which has no blood or nerve supply, chondrocytes show little metabolic activity with low turnover of matrix components. Under conditions of stress because of biomechanical factors, however, chondrocytes are capable of producing mediators that are associated with inflammation, including cytokines such as interleukin-1 and tumor necrosis factor-alpha, which in turn stimulate the production of prostaglandins and nitric oxide. Chondrocytes also express receptors for these mediators, which accumulate at high local concentrations and can act in an autocrine-paracrine fashion to feedback-regulate chondrocyte responses. Prostaglandin E-2 can exert catabolic or anabolic effects depending on the microenvironment. Nitric oxide can promote cellular injury and increase chondrocyte susceptibility to cytokine-induced apoptosis. Because crosstalk between these mediators produces complex modulation of catabolic and anabolic pathways, further studies in vitro and in vivo are required to elucidate their precise roles in osteoarthritis.
引用
收藏
页码:S37 / S46
页数:10
相关论文
共 166 条
[1]   Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis [J].
Abramson S.B. ;
Attur M. ;
Amin A.R. ;
Clancy R. .
Current Rheumatology Reports, 2001, 3 (6) :535-541
[2]   Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: A hypothesis [J].
Aigner, T ;
Dudhia, J .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) :287-291
[3]   Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type IIIL-1 decoy receptor - Potential for pharmacological intervention [J].
Attur, MG ;
Dave, M ;
Cipolletta, C ;
Kang, P ;
Goldring, MB ;
Patel, IR ;
Abramson, SB ;
Amin, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40307-40315
[4]   The interleukin 1 receptor: Ligand interactions and signal transduction [J].
Auron, PE .
CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (3-4) :221-237
[5]  
Badger AM, 1998, J IMMUNOL, V161, P467
[6]  
Badger AM, 2000, ARTHRITIS RHEUM, V43, P175, DOI 10.1002/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO
[7]  
2-S
[8]   EFFECTS OF PROSTAGLANDIN-E1 ON COLLAGEN PRODUCTION AND DEGRADATION IN HUMAN-FETAL LUNG FIBROBLASTS [J].
BARILE, FA ;
RIPLEYROUZIER, C ;
SIDDIQI, ZEA ;
BIENKOWSKI, RS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 265 (02) :441-446
[9]   Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the litigation of PPARγ [J].
Bell-Parikh, LC ;
Ide, T ;
Lawson, JA ;
McNamara, P ;
Reilly, M ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06) :945-955
[10]   Signaling transduction: target in osteoarthritis [J].
Berenbaum, F .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (05) :616-622